HOTH vs XYL · rev $1.24B vs P/E 27, rev $4.46B
Hoth Therapeutics Inc (HOTH) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
HOTH currently screens at market cap $15.5M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the HOTH and XYL stock pages for the full models.
Not investment advice.